Skip to main content
. 2018 Jul 27;19(8):2199. doi: 10.3390/ijms19082199

Figure 1.

Figure 1

Recommendations for the management of patients according to the presence of different HBV and HCV markers. NAs, nucleoside analogues; ALT, alanine aminotransferase; TNF-α, tumor necrosis factor-α.